Skip to content
PreclinicalResearch compound

Antibalder

Research-use capsule against hair loss that combines minoxidil and the peptide GHK-Cu; the combination has not been studied in humans.

Antibalder vial

DETAILED OVERVIEW

What is Antibalder?

Antibalder is a research-use capsule that combines two hair-loss ingredients: minoxidil and GHK-Cu, a short protein chain (peptide) bound to copper. The combination is not approved as a medicine anywhere, although oral minoxidil on its own is prescription-only.

Minoxidil widens blood vessels, increases the blood supply of the hair follicle and lengthens the growth phase of the hair. In lab experiments GHK-Cu boosted the growth of human hairs. Each ingredient has been studied extensively on its own, but the effect and safety of the combination itself have not been studied in humans. Oral minoxidil can cause fluid retention, a racing heartbeat and unwanted body and facial hair growth. It must not be used after a recent heart attack, with active heart-muscle circulation problems, or in pregnancy and breastfeeding, and its use generally calls for medical supervision.

Type

Fixed-dose oral combination (research capsule)

Components

GHK-Cu (copper tripeptide-1 complex) + Minoxidil

Structure

GHK-Cu: Gly-His-Lys · Cu²⁺ + Minoxidil: piperidinopyrimidine

GHK-Cu

CAS 89030-95-5 · C₁₄H₂₄CuN₆O₄ · ~403.92 g/mol

Minoxidil

CAS 38304-91-5 · C₉H₁₅N₅O · ~209.25 g/mol

Molecular weight

GHK-Cu ~403.92 · Minoxidil ~209.25 g/mol

Composition

This stack contains the following peptides

Data console

Lab data

ClassificationFixed-dose oral combination (research capsule)
StructureGHK-Cu: Gly-His-Lys · Cu²⁺ + Minoxidil: piperidinopyrimidine
Molecular weightGHK-Cu ~403.92 · Minoxidil ~209.25 g/mol
Target areaHair follicle, dermal papilla, scalp microcirculation
StorageRoom temperature, protected from light, kept desiccated
StabilitySealed bottle, tamper-evident closure; details on the CoA

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Fluid retention and edema (oral minoxidil component): sodium and water retention, ankle or facial swelling, weight gain; more pronounced at higher systemic exposure.
  • Reflex tachycardia and palpitations: vasodilation can trigger a compensatory rise in heart rate, which may worsen angina.
  • Hypertrichosis (unwanted body and facial hair): the most common reason for stopping systemic minoxidil, more pronounced in women.
  • Initial paradoxical shedding (telogen effluvium): a transient increase in hair loss in the first weeks before regrowth begins, not a treatment failure.
  • GHK-Cu component: the copper tripeptide is generally well tolerated; a theoretical concern is prolonged high copper intake (monitoring copper balance is reasonable with long-term use).
  • Combination uncertainty: the fixed GHK-Cu + oral minoxidil combo has not been studied for human safety or pharmacokinetics on its own; risk is inferred from the components.

Contraindications · 5

  • Pheochromocytoma: oral minoxidil may provoke catecholamine release and is therefore contraindicated.
  • Acute myocardial infarction, active ischemia or significant pericardial effusion: reflex tachycardia and increased cardiac workload contraindicate oral minoxidil.
  • Pregnancy and breastfeeding: minoxidil is excreted in breast milk and fetal safety is not established; not justified for alopecia.
  • Known hypersensitivity to minoxidil, GHK-Cu or any excipient, or Wilson's disease / copper-metabolism disorder (due to the copper content).
  • Unsupervised self-treatment: because of oral minoxidil's systemic effects (blood pressure, heart rate, fluid balance) the fixed oral combo is not advised without monitoring.

Related Hair & Skin

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Antibalder?

Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.